References
- Yang Y. C., Ricciardi S., Ciarletta A., Calvetti J., Kelleher K., Clark S. C. Expression cloning of a cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40. Blood 1989; 74: 1880–1884
- Lu L., Leemhuis T., Srour E. F., Yang Y. C. Human interleukin (IL)-9 specifically stimulates proliferation of CD 34+++DR+CD33– erythroid progenitors in normal human bone marrow in the absence of serum. Exp Hematol 1992; 20: 418–424
- Donhaue R. E., Yang Y. C., Clark S. C. Human P40 T-cell growth factor (Interleukin-9) supports erythroid colony formation. Blood 1990; 75: 2271–2275
- Lemoli R. M., Fortuna A., Fogli M., Motta M. R., Rizzi S., Benini C., Tura S. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD 34+ and CD 34+ CD 33– DR- cells. Exp Hematol 1994; 22: 919–923
- Hultner L., Druez C., Moeller J., Schmitt E., Uyttenhove C., Rude E., Dormer P., Van Snick J. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to a novel mouse T-cell growth factor p40/TCGF III (interleukin 9). Eur J Immunol 1990; 20: 1413–1416
- Miyazawa K., Hendrie P. C., Kim Y. K., Mantel C., Yang Y. C., Kwon B. S., Broxmeyer H. E. Recombinant human interleukin-9 induces protein tyrosine phosphorylation and synergizes with steel factor to stimulate proliferation on the human factor-dependent cell line MO7e. Blood 1992; 80: 1685–1692
- Lemoli R. M., Fortuna A., Tafuri A., Fogli M., Amabile M., Grande A., Ricciardi M. R., Petrucci M. T., Bonsi L., Bagnara G. P., Visani G., Martinelli G., Ferrari S., Tura S. Interleukin-9 stimulates the proliferation of human rnyeloid leukemic cells. Blood 1996; 87: 3852–3859
- Lemoli R. M., Gulati S. C., Strife A., Lambek C., Perez A., Clarkson B. D. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Leukemia 1991; 5: 386–391
- Lemoli R. M., Fogli M., Fortuna A., Amabile M., Zucchini P., Grande A., Martinelli G., Ferrari S., Tura S. Interleukin 11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukemic cells. Br J Haematol 1995; 91: 319–326
- Tafuri A., Lemoli R. M., Chen R., Gulati S. C., Clarkson B. D., Andreeff M. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cells sensitization to cycle specific and cycle non-specific drugs. Leukemia 1994; 5: 749–757
- Andreeff M., Assing G., Cirrincione C. Prognostic value of DNA/RNA flow cytometry in myeloblas-tic and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multivariate analysis. Ann NY Acad Sci 1984; 406: 387–406
- Darzynkiewicz Z., Bruno S., Del Bino G., Gorezyca W., Holtz M. A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795–808
- Houssiau F. A., Renauld J. C., Fibbe W. E., Van Snick J. IL-2 dependence of IL-9 expression in human T lymphocytes. J Immunol 1992; 148: 3147–3151
- Merz H., Houssiau F. A., Orscheschek K., Renauld J. C., Fliedner A., Herin M., Noel H., Kadin M., Mueller-Hermelink H. K., Van Snick J., Feller A. C. Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 1991; 78: 1311–1317
- Gruss H. J., Brach M. A., Drexler H. G., Bross K. J., Hermann F. Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Stemberg cells. Cancer Res 1992; 52: 1026–1031
- Renanld J. C., Goethals A., Houssiau F., Merz H., Van Roost E., Van Snick J. Human P40/IL-9 expression in activated CD4+ cells, genomic organization and comparison with the mouse gene. J Immunol 1990; 144: 4235–4241
- Renauld J. C., Van Der Lugt N., Vink A., Van Roon M., Godfraind C., Wamier G., Merz H., Feller A., Berns A., Van Snick J. Thymic lymphomas in IL-9 transgenic mice. Oncogene 1994; 9: 1327–1332
- Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 2844–2853
- Renauld J. C., Vink A., Louahed J., Van Snick J. Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 1995; 85: 1300–1305
- Tafuri A., Andreeff M. Kinetic rationale for cyto-sine-induced recruitment of myeloblastic leukemia followed by cicle-specific chemotherapy in vitro. Leukemia 1990; 12: 826–834
- Cluitmans F. H. M., Esendam B. H. J., Landegent J. E., Willemze R., Falkenburg F. J. H. Consitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood 1995; 85: 2038–2044